Investment Trust Insider - Comment & Analysis
Daniel Koller: biotech is heading for another blockbuster year
The investment risks in biotechnology are clear but with new drug approvals picking up despite US political uncertainty, so are the sector's prospects, says co-manager of BB Healthcare.
James Carthew: there is a future for quality ‘zeros’
The pool of zero dividend preference shares is shrinking as the split capital investment trusts that issue them mature and wind up. One new issue of these useful capital growth investments is on the horizon, however.
Trusts take oh-so teeny-weeny steps to cut charges
Jupiter US Smaller Companies and Henderson Eurotrust have negotiated small fee reductions with their fund managers. Should they do more?
Cheap platforms for buy-and-hold investment trust investors
Investment trust investors can drive down their annual platform costs to just 0.1% - a ‘steal’ according to one expert - by restricting themselves to just four trades a year.
Stifel upgrades Edinburgh after Barnett trust de-rates
Analysts at Stifel have turned ‘positive’ on Edinburgh as shares in Mark Barnett’s investment trust trail at their widest discount in five years.
Four trusts and stocks looking to be the next Lindsell Train
Lindsell Train shares have soared on their stake in Nick Train and Michael Lindsell's fund management business. Other funds and companies are trying to follow their magic recipe.
Investment Trust Watch: cheap and dear trusts
Our weekly look at the changing discounts and premiums on investment trust share prices.
Ian Cowie: why Fidelity China is the emerging trust for me
You don’t need to be a communist or be invited to the National Congress jamboree to see money-making opportunities in China.
Citywire launches inaugural Investment Trust Awards
Citywire is delighted to reveal the short-lists for its first Investment Trust Awards. The winners will be announced at an event next month in London.
Investment Trust Watch: less pricey property
Shares in property trusts look better value, but the huge discount on one fund in the sector comes with complications.